Effect of sodium-glucose cotransporter 2 inhibitor in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a propensity score-matched analysis of real-world data.

Taeang Arai,Masanori Atsukawa,Akihito Tsubota,Shigeru Mikami,Hiroki Ono,Tadamichi Kawano,Yuji Yoshida,Tomohide Tanabe,Tomomi Okubo,Korenobu Hayama,Ai Nakagawa-Iwashita,Norio Itokawa,Chisa Kondo,Keiko Kaneko,Naoya Emoto,Mototsugu Nagao,Kyoko Inagaki,Izumi Fukuda,Hitoshi Sugihara,Katsuhiko Iwakiri

Effect of sodium-glucose cotransporter 2 inhibitor in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a propensity score-matched analysis of real-world data.

2021

Background:Although sodium-glucose cotransporter 2 inhibitors (SGLT2-Is) improve not only glycemic control but also liver inflammation and fatty changes in patients with non-alcoholic fatty liver d...

Keywords:

Gastroenterology
Internal medicine
Glycemic
Inflammation
Cotransporter
Propensity score matching
Type 2 Diabetes Mellitus
Disease
Medicine
Fatty liver
Transient elastography

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations